Stocks TelegraphStocks Telegraph
Stock Ideas

PBM Stock Performance and Key Statistics

NASDAQ : PBM

Psyence Biomedical

$2.50
-0.1161-4.44%
At Close 4:00 PM
$3.07
+0.57+22.80%
After-Market 08:30 PM

stock performance chart

PBM Fundamental Analysis

Based on recent data, Psyence Biomedical Ltd. (PBM) shows an Average True Range (ATR) of 0.74 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 379.54K, indicating liquidity. These fundamental metrics provide insight into PBM's underlying financial health and market activity.

ATR0.74
Enterprise Value-
Avg Vol (3 Months)379.54K
Avg Vol (10 Days)31.95K

PBM Technical Analysis Indicators

Psyence Biomedical Ltd. (PBM) technical indicators as of February 22, 2026: the SMA 20 is -26.36%, SMA 50 at -52.14%, and SMA 200 at -87.52%. The RSI 14 value is 31.04, suggesting its current momentum. These technical analysis signals help assess PBM's price trends and potential future movements.

SMA 20-26.36%
SMA 50-52.14%
SMA 200-87.52%
RSI 1431.04

PBM Stock Performance Overview

Psyence Biomedical Ltd. (PBM) stock performance overview as of February 22, 2026: The 52-week high is $74.938 (currently -96.66% below), and the 52-week low is $0.615 (currently 3.31% above). Over the past year, PBM's performance is -94.87%, compared to the S&P 500's 7.96% change.

52-Week High74.938
52-Week High Chg-96.66%
52-Week Low0.6147
52-Week Low Chg+3.31%
S&P 500 52-Week Chg7.96%

Psyence Biomedical Ltd. (PBM) Historical Stock Performance

According to market data, Psyence Biomedical Ltd. (PBM) stock's recent performance metrics show that over the last month, PBM is -56.21%, with a Year-to-Date (YTD) performance of -11.07%. Over the past year, the stock has seen a -94.87% change. These figures summarize PBM's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High3.112.6417.62534.62574.93812.64
Low2.420.62540.61470.61470.61470.6147
Performance-16.25%-56.21%-80.58%-86.76%-94.87%-11.07%

Industry Analysis and Valuation

According to current financial data, PBM stock's P/E (TTM) ratio is -6.05, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.23. Key valuation ratios for PBM, including P/S (N/A), P/B (0.31), and P/FCF (N/A), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationPBMSector MedianIndustry AvgS&P 500
P/E (TTM)-6.05-1.23-5.1632.59
P/S (TTM)N/A3.71464.925.98
P/B (TTM)0.310.648.485.16
P/FCF (TTM)N/A-7.99-218.5730.24

Frequently Asked Questions

How is PBM price-to-earnings ratio currently?
PBM has a current P/E ratio of -6.05
How are PBM's price-to-sale and price-to-book ratios?
The PBM stock has a trailing twelve month price-to sales (P/S) ratio of N/A while its price-to-book (P/B) value is 0.31.
Is Psyence Biomedical Ltd.'s price-to-cashflow ratio high or low?
PBM's price-to-free-cashflow (P/FCF) ratio is N/A, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for PBM?
Based on PBM's recent bid, its distance from 20 days simple moving average is -26.36%. It is -52.14% apart from 50 days simple moving average, and it is -87.52% apart from 200 days simple moving average.
What is the 52-week price range for PBM?
The 52-week high for PBM is $468.36 which is -96.66% away from the current price level whereas the distance of that from the 52-week low of $2.48 stands at 3.31%.
An overview of PBM's stock performance: how did it fare?
The performance of PBM stock was not encouraging with most of its significant price indicators in red. Psyence Biomedical Ltd.(NASDAQ: PBM) shares have moved downward -4.44% or - $0.12 in the latest trading session and have lost -11.07% year-to-date (YTD). The stock has lost nearly -94.87% over the past year. After moving -80.58% over the trailing 3-month period, the stock is -86.76% lower in the 6-month period. Looking at its performance over the shorter term, it'slost -16.25% a week and -56.21% a month.
What is PBM's 14-day relative strength index (RSI)?
The current 14-day RSI for PBM stock is 31.04. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For PBM, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Psyence Biomedical Ltd. (PBM) has a 14-day ATR of 0.74.
What is PBM's current enterprise value?
After closing at $2.62 with 19.02K of its shares outstanding, the current enterprise value of PBM is roughly -.
Over the past year, how has the stock price of PBM changed?
Psyence Biomedical Ltd. (NASDAQ: PBM) is down -94.87% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 7.96%. PBM stock price is also down -11.07% on its value in year-to-date trading.
What is the average trading volume for PBM shares?
The number outstanding shares of PBM is 19.02K, and of these 100% shares are freely available for trading. On average, PBM stock has traded 31.95K shares per day for the past 10 days. A total of 38.18K shares changed hands during the last trading session with the average session volume of 160.88K shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph